BNC Korea Co Ltd 256840
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- KRW 6,180.00
- Day Range
- KRW 6,120.00–6,360.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 6,190.00 / KRW 6,200.00
- Market Cap
- KRW 411.95 Bil
- Volume/Avg
- 702,066 / 6.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- 24.90
- Price/Sales
- 5.19
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- < 0.01%
Company Profile
BNC Korea Co Ltd is a Korean healthcare company. The company is engaged in manufacturing medicinal chemicals, antibiotics, and biological products. IIts product offering includes cutegel, cutegel lidocaine, FLORE lidocaine, ChungA-an, cutegel-M under the HA filler product line. While it also offers Skin booster filler, hibarry, gentaQ, and I.st products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 206
- Website
- http://www.bnckorea.co.kr
Comparables
Valuation
Metric
|
256840
|
000640
|
140410
|
---|---|---|---|
Price/Earnings (Normalized) | 24.90 | 20.51 | — |
Price/Book Value | 1.98 | 0.69 | 21.73 |
Price/Sales | 5.19 | 0.62 | 33.69 |
Price/Cash Flow | 20.98 | 5.12 | — |
Price/Earnings
256840
000640
140410
Financial Strength
Metric
|
256840
|
000640
|
140410
|
---|---|---|---|
Quick Ratio | 6.49 | 0.44 | 2.17 |
Current Ratio | 7.32 | 0.66 | 2.51 |
Interest Coverage | 21.88 | 3.70 | −43.24 |
Quick Ratio
256840
000640
140410
Profitability
Metric
|
256840
|
000640
|
140410
|
---|---|---|---|
Return on Assets (Normalized) | 10.55% | 3.28% | −17.65% |
Return on Equity (Normalized) | 12.49% | 6.15% | −33.91% |
Return on Invested Capital (Normalized) | 10.73% | 4.65% | −28.13% |
Return on Assets
256840
000640
140410
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Rwdyslpmq | Npjkx | $69.8 Bil | |
ZTS
| Zoetis Inc Class A | Bgtxtvkpt | Czdn | $68.9 Bil | |
HLN
| Haleon PLC ADR | Pgxfmmgf | Lbtf | $37.7 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Pshdqptps | Nlc | $14.8 Bil | |
VTRS
| Viatris Inc | Vkljkfsk | Zgyd | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Nbmfjnqd | Lvnd | $11.9 Bil | |
CTLT
| Catalent Inc | Dzjnsnb | Fmmnp | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Dbfcqnq | Tdh | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Wdkjtjy | Ghth | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jhvbvklqd | Wmyfc | $3.5 Bil |